Amanote Research
Register
Sign In
Q&A: Suzanne Topalian on Immune Therapies
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nd2013-016
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
June 27, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Q&A: Lisa Coussens on Immune Reprogramming
Cancer Discovery
Oncology
Genomics of Immune Diseases and New Therapies
Annual Review of Immunology
Allergy
Immunology
The Effects of Mind-Body Therapies on the Immune System: Meta-Analysis
PLoS ONE
Multidisciplinary
Suzanne Eaton (1959–2019)
Cell
Biochemistry
Genetics
Molecular Biology
Putting a Band-Aid on a Broken Leg: Antiseizure Medications Are Inferior to Immune Therapies in Autoimmune Epilepsy
Epilepsy Currents
Neurology
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Cancer Cell
Cancer Research
Oncology
Cell Biology
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis
Gastroenterology
Hepatology
Gastroenterology
Advances in Immune-Modulating Therapies to Treat Atherosclerotic Cardiovascular Diseases
Therapeutic Advances in Vaccines
What the Oncologist Needs From the Pathologist for Immune Therapies
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology